Company profile: Prytime Medical
1.1 - Company Overview
Company description
- Provider of minimally invasive hemorrhage-control solutions, including ER-REBOA PLUS catheters with integrated central aortic pressure monitoring and guidewire compatibility; pREBOA-PRO catheters with a semi-compliant balloon, in-line pressure relief, and blood pressure monitoring; a REBOA Catheter Convenience Set for femoral artery access, placement, and fixation; and the ARTI simulator for arterial access and catheter training.
Products and services
- PREBOA-PRO™ Catheter: Delivers temporary occlusion of large vessels and blood pressure monitoring using a semi-compliant balloon and an in-line pressure relief valve to manage inflation
- Semi-compliant
- ER-REBOA™ PLUS Catheter: Provides temporary occlusion of large vessels during hemorrhage control, with integrated central aortic pressure monitoring and guidewire compatibility for placement
- Guidewire-compatible
- REBOA Catheter Convenience Set: Supplies a kit containing components needed for femoral artery access, REBOA placement, and external fixation of the catheter to maintain position
- Kit-based
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Prytime Medical
Naviswiss
HQ: Switzerland
Website
- Description: Provider of handheld, miniaturized surgical measuring, tracking, and navigation systems, including imageless navigation for hip and knee arthroplasty, CT-based hip navigation with digital cup alignment and patient-specific visualization, and CT-based pre-operative planning. Products include NAVISWISS HIP, NAVISWISS HIP CT, NAVISWISS KNEE, NAVIPLAN, CLIPON, LOCAS, and NAVITAGS.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Naviswiss company profile →
Venclose
HQ: United States
Website
- Description: Provider of medical technology solutions for the treatment of chronic venous insufficiency, aiming to improve the physician and patient experience by commercializing RF therapy. Founded in 2014 and headquartered in San Jose, California.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Venclose company profile →
Neo Medical
HQ: Switzerland
Website
- Description: Provider of medtech solutions to achieve a more Functional Fusion in spinal surgery, aiming to transform the current approach with efficient, versatile, and high-quality systems that address healthcare cost optimization.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neo Medical company profile →
Hansen Medical
HQ: United States
Website
- Description: Provider of advanced medical robotics for accurate positioning and control of catheter-based technologies; designs and manufactures the Sensei Robotic Catheter System.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Hansen Medical company profile →
IMRIS
HQ: United States
Website
- Description: Provider of integrated image-guided therapy environments and intraoperative imaging solutions. Products include VISIUS Surgical Theatre and InVision operating suites that integrate MRI, CT, and fluoroscopy; ceiling-mounted iMRI systems that move between diagnostic and operating rooms; customized surgical theatre design, installation, clinical training and support, and MR-conditional surgical tables.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full IMRIS company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Prytime Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Prytime Medical
2.2 - Growth funds investing in similar companies to Prytime Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Prytime Medical
4.2 - Public trading comparable groups for Prytime Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →